The Beauty Health Company (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
1.610
-0.050 (-3.01%)
Nov 4, 2024, 4:00 PM EST - Market closed
The Beauty Health Company Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for SKIN stock have an average target of 2.29, with a low estimate of 1.00 and a high estimate of 5.00. The average target predicts an increase of 42.24% from the current stock price of 1.61.
Analyst Consensus: Hold
* Price targets were last updated on Aug 12, 2024.
Analyst Ratings
The average analyst rating for SKIN stock from 10 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 6 | 6 | 6 | 6 |
| Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $2 → $1.25 | Hold | Maintains | $2 → $1.25 | -22.36% | Aug 12, 2024 |
| Piper Sandler | Piper Sandler | Sell Reiterates $1.5 → $1 | Sell | Reiterates | $1.5 → $1 | -37.89% | Aug 9, 2024 |
| Stifel | Stifel | Hold Maintains $4 → $2 | Hold | Maintains | $4 → $2 | +24.22% | Jul 26, 2024 |
| Piper Sandler | Piper Sandler | Sell Maintains $2.5 → $1.5 | Sell | Maintains | $2.5 → $1.5 | -6.83% | Jul 11, 2024 |
| DA Davidson | DA Davidson | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +210.56% | May 13, 2024 |
Financial Forecast
Revenue This Year
339.24M
from 397.99M
Decreased by -14.76%
Revenue Next Year
366.63M
from 339.24M
Increased by 8.07%
EPS This Year
-0.20
from -0.76
EPS Next Year
-0.16
from -0.20
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 358.8M | 421.0M | 449.4M | ||
| Avg | 339.2M | 366.6M | 412.1M | ||
| Low | 313.4M | 303.6M | 360.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -9.8% | 24.1% | 22.6% | ||
| Avg | -14.8% | 8.1% | 12.4% | ||
| Low | -21.3% | -10.5% | -1.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.14 | 0.26 | 0.38 |
| Avg | -0.20 | -0.16 | -0.04 |
| Low | -0.27 | -0.34 | -0.25 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.